FDA Hammers Active Ingredient Maker Over 'Severe Hazard'

Law360, New York (February 12, 2014, 6:13 PM EST) -- A manufacturer of active pharmaceutical ingredients created a “severe hazard” by adopting substandard labeling and storage practices at plants in Arizona and Hong Kong, according to a U.S. Food and Drug Administration warning letter released Wednesday.

In one of the most notable findings, the FDA said that it encountered a container whose labels indicated the presence of an inactive ingredient, but that testing of the contents revealed a variety of different substances used to treat medical conditions.

“The unacceptable practices that resulted in this mislabeling incident...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.